Who owns the THERAQ7 trademark?

The THERAQ7 trademark is owned by Jinke Group USA Inc..

What class is the THERAQ7 trademark registered in?

The THERAQ7 trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations).

What is the serial number for THERAQ7?

The USPTO serial number for THERAQ7 is 86898227.

What is the registration number for THERAQ7?

THERAQ7 is registered under USPTO registration number 5098944.

Sealvo

Home Search: THERAQ7THERAQ7 #86898227

Back

Updated Sep 18, 2026·33 searches this week

View on USPTO TSDR Find similar marks

THE

USPTO Trademark Record

REGISTERED

THERAQ7

SN 86898227·Reg 5098944·Filed Feb 04, 2016

Owner Jinke Group USA Inc.

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.

THERAQ7 (Serial No. 86898227), Registration No. 5098944, is a registered US trademark filed on Feb 04, 2016 by Jinke Group USA Inc.. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations).

renewal 10y period: December 14, 202687 days remaining

Conflict Analysis

Full conflict analysis for THERAQ7 (SN 86898227) against the USPTO database with detailed risk factor explanations. AI-powered — takes ~1-2 min.

Mark Intelligence

THERAQ7 (Reg. #5098944) is a registered US trademark that has been protecting its owner, Jinke Group USA Inc., since 2016. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations). Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 1 opposition proceeding during prosecution.

FILED

Feb 04, 2016

SERIAL

86898227

REG#

5098944

REGISTERED

Dec 13, 2016

Filing Information

StatusREGISTERED

Filing DateFeb 04, 2016

Serial Number86898227

Registration No.5098944

Registration DateDec 13, 2016

Status DateJul 14, 2023

Published for OppositionSep 27, 2016

Filing Basis & Declarations

Standard Characters ClaimedFiled as Use ApplicationUse Application CurrentlySection 8 AcceptedTrademark

International Filings

Madrid Protocol1 filings

This mark has 1 Madrid Protocol filing on record with the USPTO.

1410326

480Apr 20, 2018

Source: USPTO Madrid International Filing Requests

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 006, 018, 044, 046, 051, 052

First use anywhere: Apr 01, 2015

First use in commerce: Apr 01, 2015

This description is as filed with the USPTO and defines the scope of trademark protection.

Run a conflict check

Search by serial number, mark name, or logo. See conflicting marks ranked by risk with clear explanations of what contributed.

Run conflict check

Status History

19 events

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

Dec 13, 2025

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

REGISTERED - SEC. 8 (6-YR) ACCEPTED

Jul 14, 2023

REGISTERED - SEC. 8 (6-YR) ACCEPTED

NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED

Jul 14, 2023

NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

Jul 06, 2023

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

TEAS SECTION 8 RECEIVED

Jan 11, 2023

TEAS SECTION 8 RECEIVED

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

Dec 13, 2021

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

REGISTERED-PRINCIPAL REGISTER

Dec 13, 2016

REGISTERED-PRINCIPAL REGISTER

PUBLISHED FOR OPPOSITION

Sep 27, 2016

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Sep 27, 2016

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Sep 07, 2016

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

TEAS/EMAIL CORRESPONDENCE ENTERED

Aug 16, 2016

TEAS/EMAIL CORRESPONDENCE ENTERED

APPROVED FOR PUB - PRINCIPAL REGISTER

Aug 16, 2016

APPROVED FOR PUB - PRINCIPAL REGISTER

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Aug 15, 2016

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Aug 15, 2016

CORRESPONDENCE RECEIVED IN LAW OFFICE

ASSIGNED TO EXAMINER

May 19, 2016

ASSIGNED TO EXAMINER

NON-FINAL ACTION WRITTEN

May 19, 2016

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

May 19, 2016

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

May 19, 2016

NOTIFICATION OF NON-FINAL ACTION E-MAILED

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Feb 10, 2016

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Other Marks by Jinke Group USA Inc.

Additional USPTO filings from the same owner.

MYR

MYRTIPRO

86574637

Jinke Group USA Inc.

REGISTERED

LIN

LINGONMAX

86609738

Jinke Group USA Inc.

REGISTERED

CYA

CYANIMAX

98221445

Jinke Group USA, Inc.

REGISTERED

THE

THERAPRIME

86898209

Jinke Group USA Inc.

REGISTERED

Other Marks by Rose W. Tsai

Additional USPTO filings handled by the same attorney of record.

KOW

KOWA USA INC., CA U.S.A. WILD ABALONE PRODUCT OF MEXICO CALSTAR CALSTAR

88317450

REGISTERED

TAL

TALLWOOD

99043336

REGISTERED

MYR

MYRTIPRO

86574637

REGISTERED

MAG

MAGVIA

86609708

REGISTERED

THERAQ7

Run a conflict check

Other Marks by Jinke Group USA Inc.

Other Marks by Rose W. Tsai

Get pre-filing clearance

Search 15M+ trademarks

Resources

Company